Pol, Stanislas
Parlati, Lucia
Jadoul, Michel
Article History
First Online: 19 November 2018
Competing interests
: S.P. has acted as a speaker or board member for Bristol-Myers Squibb, Boehringer Ingelheim, Janssen, Gilead, Roche, MSD and Abbvie, and has received grants from Bristol-Myers Squibb, Gilead, Roche, Abbvie and MSD. M.J. has acted as a speaker for MSD and Abbvie, and as a Board Member for MSD. He has also received a grant from MSD. He co-chaired the 2018 update of the HCV and CKD KDIGO Guideline and is co-chair elect of KDIGO. L.P. declares no competing interests.